ѻý

Biological Age Predicts Dementia; APOE4 and Tau Patterns; AI and MS Brain Changes

<ѻý class="mpt-content-deck">— News and commentary from the world of neurology and neuroscience
MedpageToday
Neuro Break over a computer rendering of neurons.

Advanced calculated from clinical biomarkers predicted risks of dementia or stroke, U.K. Biobank data showed. (Journal of Neurology, Neurosurgery, and Psychiatry)

Carriers of APOE4 showed earlier . (JAMA Neurology)

A single-center study found , immune activation, or central nervous system injury in cerebrospinal fluid in patients with long COVID cognitive problems. (Journal of Infectious Diseases)

Changing or combining like deep brain stimulation and pump therapies was associated with an improvement in motor scores or subjective symptom reporting. (Neurology)

Women with a stroke history thought they would receive based on their gender or race or ethnicity, survey data showed. (Stroke)

Retina pathology may help or monitor disease progression, but standards need to be harmonized. (Alzheimer's & Dementia)

A gene therapy strategy selectively and affected motor symptoms in rodent and primate models of Parkinson's disease. (Cell)

A clinically integrated AI-based MRI tool showed promise in detecting . (NPJ Digital Medicine)

Cognitive behavioral therapy can significantly lower in myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS), a meta-analysis suggested. (Psychological Medicine)

  • Judy George covers neurology and neuroscience news for ѻý, writing about brain aging, Alzheimer’s, dementia, MS, rare diseases, epilepsy, autism, headache, stroke, Parkinson’s, ALS, concussion, CTE, sleep, pain, and more.